The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-{5-[1-(1-ethyl-3-carboxy-4-oxo-6-fluoro-7-quinolyl)-3-(1,3-diazabicyclononyl)]pentyl}-6-(3-ethyl-4-methylanilino)uracil ID: ALA379011
PubChem CID: 11636374
Max Phase: Preclinical
Molecular Formula: C37H45FN6O5
Molecular Weight: 672.80
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CCc1cc(Nc2cc(=O)n(CCCCCN3CC4CCCN(c5cc6c(cc5F)c(=O)c(C(=O)O)cn6CC)C4C3)c(=O)[nH]2)ccc1C
Standard InChI: InChI=1S/C37H45FN6O5/c1-4-24-16-26(12-11-23(24)3)39-33-19-34(45)44(37(49)40-33)14-8-6-7-13-41-20-25-10-9-15-43(32(25)22-41)31-18-30-27(17-29(31)38)35(46)28(36(47)48)21-42(30)5-2/h11-12,16-19,21,25,32,39H,4-10,13-15,20,22H2,1-3H3,(H,40,49)(H,47,48)
Standard InChI Key: CHUPOJRARUNHOV-UHFFFAOYSA-N
Molfile:
RDKit 2D
49 54 0 0 0 0 0 0 0 0999 V2000
-1.4522 -0.8367 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7360 -1.2504 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.0249 -0.8350 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0253 -0.0092 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.7430 0.3997 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4603 -0.0131 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1653 -1.2556 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.8831 -0.8449 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8842 -0.0194 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5971 0.3871 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.3112 -0.0277 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.3038 -0.8574 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5862 -1.2644 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6914 -1.2485 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.7448 1.2253 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.6894 0.4029 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4056 -0.0065 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1204 0.4055 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8325 -0.0038 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.0361 0.3779 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6014 1.2127 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8922 1.6312 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5472 0.4082 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2635 -0.0011 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.3545 -0.8172 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0209 0.3391 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5760 -0.2744 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1609 -0.9875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5713 -1.6980 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3944 -1.7017 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8053 -0.9886 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3973 -0.2718 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.7949 0.4511 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6177 0.4611 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7618 1.8742 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3680 1.1515 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5914 1.8920 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0197 1.1806 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8439 1.1942 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.2460 1.9177 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8218 2.6291 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9914 2.6170 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5639 3.3250 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.2214 3.3509 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0469 3.3636 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.7996 4.0587 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.5428 1.1315 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
9.2653 0.4850 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8655 -0.2367 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23 24 1 0
24 25 1 0
11 12 2 0
5 6 1 0
25 28 1 0
27 26 1 0
26 24 1 0
27 28 1 0
12 13 1 0
13 8 2 0
1 2 1 0
3 14 2 0
1 7 1 0
5 15 2 0
27 32 1 0
28 29 1 0
29 30 1 0
30 31 1 0
31 32 1 0
32 33 1 0
4 16 1 0
33 34 1 0
34 38 2 0
7 8 1 0
37 35 2 0
16 17 1 0
35 36 1 0
36 33 2 0
37 38 1 0
1 6 2 0
17 18 1 0
8 9 1 0
18 19 1 0
2 3 1 0
11 20 1 0
37 42 1 0
38 39 1 0
39 40 1 0
40 41 2 0
41 42 1 0
9 10 2 0
42 43 2 0
10 21 1 0
41 44 1 0
3 4 1 0
44 45 1 0
21 22 1 0
44 46 2 0
10 11 1 0
36 47 1 0
19 23 1 0
39 48 1 0
4 5 1 0
48 49 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 672.80Molecular Weight (Monoisotopic): 672.3435AlogP: 5.09#Rotatable Bonds: 12Polar Surface Area: 132.67Molecular Species: ZWITTERIONHBA: 9HBD: 3#RO5 Violations: 2HBA (Lipinski): 11HBD (Lipinski): 3#RO5 Violations (Lipinski): 3CX Acidic pKa: 5.51CX Basic pKa: 8.70CX LogP: 3.04CX LogD: 3.03Aromatic Rings: 4Heavy Atoms: 49QED Weighted: 0.18Np Likeness Score: -0.89
References 1. Zhi C, Long ZY, Manikowski A, Comstock J, Xu WC, Brown NC, Tarantino PM, Holm KA, Dix EJ, Wright GE, Barnes MH, Butler MM, Foster KA, LaMarr WA, Bachand B, Bethell R, Cadilhac C, Charron S, Lamothe S, Motorina I, Storer R.. (2006) Hybrid antibacterials. DNA polymerase-topoisomerase inhibitors., 49 (4): [PMID:16480282 ] [10.1021/jm0510023 ]